EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
29/05/2025
Voltar para busca
Dado oficial do USPTO
PURESPRING
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
04/06/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42, 44
Data de depósito
09/11/2021
Data de registro
12/12/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/12/2023
Última transação
04/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
GB
Examinador
DUBIN, DAVID
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of consists of the stylized white wording "PURESPRING" in which the tittle above the letter "I" is featured in green. The stylized wording, as illustrated in the mark, is featured on top of a teal rectangular background.
Titulares e representantes
Titulares
Purespring Therapeutics Limited
Representantes
Ben Natter Haug Partners, LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Gene therapy therapeutic productspharmaceutical and medical preparations for treating kidney disease
Classe 42
Pharmaceuticalmedical and scientific research and scientific research information in the field of gene therapy for kidney diseases; Scientific research in the field of gene therapy; Medicalpharmaceutical and scientific research services for assessing the efficiency of pharmaceutical and medical preparations and substances; Medical and scientific researchconducting clinical trials for others
Classe 44
Pharmaceutical advice and medical services; medical diagnostic and screening servicesmedical diagnostic testingmonitoring and reporting services for diagnostic or treatment purposes; healthcare services; advisory services in the fields of medicine and pharmacologymedical advisory services; consultancy and information services relating to pharmaceutical and medical preparations and substancespharmaceutical advice and medical advisory services
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/05/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/03/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
27/04/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/04/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/03/2024
FIMP
FINAL DISPOSITION PROCESSED
13/03/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/12/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/12/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/09/2023
PUBO
PUBLISHED FOR OPPOSITION
26/09/2023
GPNX
NOTIFICATION PROCESSED BY IB
25/09/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
16/09/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/09/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/09/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/09/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/08/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
30/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/08/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
23/08/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
23/08/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
23/08/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
23/05/2023
GNFR
FINAL REFUSAL E-MAILED
23/05/2023
CNFR
FINAL REFUSAL WRITTEN
23/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/04/2023
RFNT
REFUSAL PROCESSED BY IB
08/11/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/10/2022
RFRR
REFUSAL PROCESSED BY MPU
20/10/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/08/2022
CNRT
NON-FINAL ACTION WRITTEN
25/08/2022
DOCK
ASSIGNED TO EXAMINER
19/08/2022
MAFR
APPLICATION FILING RECEIPT MAILED
29/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/03/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/03/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PURESPRING ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.